Use of Ketamine in Ameliorating Opioid Withdrawal Symptoms During an Induction Phase of Buprenorphine

Pain Crises in Sickle Cell Disease: A Clinical Guide to Prevention and Treatment - PDF


Ketamine can be used in the treatment of opioid withdrawal symptoms. Here are two case discussions of treatment of withdrawal symptoms in opioid dependent patients undergoing detoxification. Our case reports endorse the hypothesis that N-methyl D-aspartate (NMDA) antagonists may selectively inhibit the expression of opiate withdrawal. The use of intravenous ketamine can be considered as a bridge to successful initiation of buprenorphine to wean the patient off from high opioid doses while providing adequate analgesia during the transition period.

Related Articles

A New Minimally Invasive Procedure for Muscle, Back,
Neck Pain and Radiculopathy – The Myofascial Nerve

This is the first description of a procedure targeting the myofascial tissues since Janet Travell’s
description of myofascial trigger points in 1942. However unlike trigger point injections, this
minimally invasive myofascial nerve injection is performed differently and targets the myofascial
tissues, peripheral innervations, posterior spinal structures and spinal nerve roots at the same
time. It is different from a trigger point injection that aims to block trigger points within a muscle.
Prolonged standing or sitting, posture and other multiple factors can create recurrent injuries
with attendant inflammation and episodically aggravate pain. Thus there is a need for a simple
intervention technique that can be performed from the medical clinic to the battlefield to quickly
relieve inflammation and prevent chronic pain.